HUP0101396A3 - Preparation of human papillomavirus e1 having helicase activity and method therefor - Google Patents

Preparation of human papillomavirus e1 having helicase activity and method therefor

Info

Publication number
HUP0101396A3
HUP0101396A3 HU0101396A HUP0101396A HUP0101396A3 HU P0101396 A3 HUP0101396 A3 HU P0101396A3 HU 0101396 A HU0101396 A HU 0101396A HU P0101396 A HUP0101396 A HU P0101396A HU P0101396 A3 HUP0101396 A3 HU P0101396A3
Authority
HU
Hungary
Prior art keywords
preparation
method therefor
human papillomavirus
helicase activity
helicase
Prior art date
Application number
HU0101396A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Publication of HUP0101396A2 publication Critical patent/HUP0101396A2/hu
Publication of HUP0101396A3 publication Critical patent/HUP0101396A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU0101396A 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor HUP0101396A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8394298P 1998-05-01 1998-05-01
PCT/CA1999/000389 WO1999057283A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Publications (2)

Publication Number Publication Date
HUP0101396A2 HUP0101396A2 (hu) 2001-08-28
HUP0101396A3 true HUP0101396A3 (en) 2006-03-28

Family

ID=22181652

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101396A HUP0101396A3 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Country Status (9)

Country Link
US (1) US6306580B1 (enExample)
EP (1) EP1073750A1 (enExample)
JP (1) JP2002513813A (enExample)
AU (1) AU767903B2 (enExample)
CA (1) CA2326402A1 (enExample)
HU (1) HUP0101396A3 (enExample)
IL (1) IL139270A0 (enExample)
NZ (1) NZ508519A (enExample)
WO (1) WO1999057283A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE387500T1 (de) * 1998-07-21 2008-03-15 Boehringer Ingelheim Ca Ltd Regionen des papillomavirus-e1-helikase beteiligt an e1 oligomerisierung
MXPA01012921A (es) 1999-06-17 2002-09-18 Boehringer Ingelheim Ltd Nuevo ensayo de atpasa.
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
AU2003215244A1 (en) * 2002-02-14 2003-09-04 Curagen Corporation Complexes and methods of using same
USD1070308S1 (en) * 2023-07-13 2025-04-15 Wolverine Outdoors, Inc. Footwear sole
USD1067594S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole
USD1067593S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464936A (en) 1990-12-21 1995-11-07 Cetus Oncology Corporation Compositions for identification of papillomavirus replication inhibitors

Also Published As

Publication number Publication date
AU3592399A (en) 1999-11-23
CA2326402A1 (en) 1999-11-11
AU767903B2 (en) 2003-11-27
NZ508519A (en) 2003-12-19
IL139270A0 (en) 2001-11-25
WO1999057283A1 (en) 1999-11-11
EP1073750A1 (en) 2001-02-07
HUP0101396A2 (hu) 2001-08-28
US6306580B1 (en) 2001-10-23
JP2002513813A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
PL350822A1 (en) Disposable wiper-cloth and method of making same
HUP0103357A3 (en) Halichondrin analogs and methods of their use and preparation
PL350826A1 (en) Disposable wiper-cloth and method of making same
GB9808052D0 (en) Implants for administering substances and methods of producing implants
AU2002239628A1 (en) Non-invasive method and system of quantifying human postural stability
AU1738200A (en) Tissue acquisition system and method of use
HU9900145D0 (en) Preparation of sterol and stanolesters
AU3068699A (en) Skin equivalent and methods of forming and using same
AU7131500A (en) Disposable filtering face mask and method of making same
ZA967654B (en) Electrodes and methods of preparation thereof
EP1183030A4 (en) PROCESS FOR THE PREPARATION AND ITS USE OF N-DESMETHYLZOPICLONE
GB9808840D0 (en) Treatment of depression and pharmaceutical preparations therefor
AU3118499A (en) Soft tissue reconstructor and method of use
EP1082466A4 (en) METHOD, REAGENT AND TEST SET FOR TYPING THE GENOME OF PAPILLOMA VIRUS
GB9819898D0 (en) New vaccine and method of use
AU4367700A (en) Human kinesins and methods of producing and purifying human kinesins
PL332761A1 (en) Method of making computer-assisted audiometric measurements and system therefor
IL141211A0 (en) Prevention and treatment of viral disease
IL139270A0 (en) Preparation of human papillomavirus e1 having helicase activity and method therefor
PL329808A1 (en) Derivatives of indolylpyrrolyden methylpyrrole and method of obtaining them
HUP0100743A3 (en) Process for preparation of simvastatin and derivatives thereof
EP1086215A4 (en) PREPARATION AND USE OF HIGHER VACCINES
AU3501700A (en) Human endokine alpha and methods of use
PL340487A1 (en) Macaroni and method of making same
AU9756898A (en) Human prostaglandin receptors and methods of use thereof

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): BELICZAY LASZLO, S.B.G. & K. BUDAPESTI NEMZETKOEZI SZABADALMI IRODA, HU

Representative=s name: DR.LANG TIVADARNE S.B.G.& K.SZABADALMI UEGYVIV, HU

FH92 Termination of representative

Representative=s name: BELICZAY LASZLO, S.B.G. & K. BUDAPESTI NEMZETK, HU

FD9A Lapse of provisional protection due to non-payment of fees